Lamivudine + Nevirapine + Zidovudine is a fixed-dose antiretroviral combination used to manage HIV-1 infection in adults and adolescents weighing 30 kg or more.
This combination is commonly used for:
• HIV-1 infection: Reduces the amount of virus in the blood by acting on the virus at different stages of its replication cycle.
• Long-term HIV management: Used as part of ongoing antiretroviral therapy to help maintain low viral load and preserve immune function.
• Combination antiretroviral therapy: Reduces the likelihood of the virus becoming resistant to treatment when compared with using a single antiretroviral agent.
Nausea
Fatigue
Headache
Diarrhoea
Rash
Lamivudine + Nevirapine + Zidovudine works by attacking the human immunodeficiency virus (HIV) at more than one point in its life cycle, helping to reduce the amount of virus in the body.
Lamivudine and Zidovudine both belong to a class of medicines called nucleoside reverse transcriptase inhibitors (NRTIs). Inside infected cells, they are converted into active forms that resemble the natural building blocks of viral DNA. When the virus tries to copy itself, these medicines get incorporated into the new viral DNA and stop it from being completed, halting the virus from multiplying.
Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works differently by binding directly to reverse transcriptase, an enzyme the virus needs to convert its genetic material into DNA. This blocks the enzyme's activity and prevents the virus from replicating.
Together, these three medicines attack the virus through different mechanisms, reducing the chance of the virus becoming resistant and helping to keep the viral load low over the long term.

BDS, MDS

BAMS, FMC, MD Resident
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Lamivudine + Nevirapine + Zidovudine may cause dizziness or fatigue. Therefore, patients should avoid driving or operating heavy machinery until they are sure about how this medication affects them.
Frequently asked questions
No, Lamivudine + Nevirapine + Zidovudine is not a steroid. It is a fixed-dose combination antiretroviral medication used to manage HIV infection.
The combination of Lamivudine + Nevirapine + Zidovudine can be taken with or without food. However, it is advisable to follow the instructions of your doctor regarding its administration.
Lamivudine + Nevirapine + Zidovudine may have mood-related side effects, such as depression or anxiety, but these are not common. If you notice any mood changes while taking these medications, it's important to talk to your doctor.
The medication may lead to changes in body fat distribution, which might include central obesity. However, it does not specifically cause weight gain.
No, you should not stop taking this medicine before the full prescribed period is complete, even if you feel better after a few doses.
Lamivudine + Nevirapine + Zidovudine is used for the management of HIV-1 infection. According to the Centers for Disease Control and Prevention, HIV-1-infected mothers should not breastfeed their infants to avoid risking postnatal transmission of HIV-1 infection.
If you have hepatitis B, your doctor will evaluate your situation and determine the best treatment plan.




Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorAdvertise with UsSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.28.8
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

